Scientific Department, Medspa, Milano, Italy.
Department of Drug Sciences, University of Pavia, Pavia, Italy.
J Cosmet Dermatol. 2023 Feb;22(2):517-528. doi: 10.1111/jocd.15215. Epub 2022 Aug 9.
Actually, the use of chemical peels in cosmetics and dermatology continues to grow due to their versatility, clinical endpoint-directed predictability, and favorable risk profile in comparison to lasers. The chemical peel is a generally safe method for treatment of some skin disorders and to refresh and rejuvenate the skin. The major challenge of chemical peels is the tolerability, that is because of sensitive skin which is one of the most common skin disorders.
The aim of this study was to evaluate the effectiveness of the new Miamo Renewal Peel Serum formulated with a pool of new generation acids (ELPA25™) on sensitive skin with respect to mandelic acid serum only and with respect to placebo comparison.
The "in vivo" study following the half-face experimental protocol active versus placebo involved 30 healthy Caucasian female volunteers between 25 and 64 years, with sensitive skin, who were divided into two different groups. ELPA25™ serum was applied in one group three times a week for 8 weeks. The other group, with the same protocol, applied an active serum containing mandelic acid, as control, versus placebo. In particular, skin moisturizing, skin viscoelastic properties, skin surface smoothness, wrinkle reduction, and stratum corneum renewal were evaluated.
Renewal Peel Serum was very well tolerated from sensitive skin. A significant decrease in skin roughness and wrinkle breadth, and an improvement in firmness and in skin elasticity, was observed after 2 months of treatment with respect both to mandelic acid serum and to placebo comparison.
Scientific protocol using self-controlled study methodology and noninvasive skin bioengineering techniques with adequate statistical methods were able to evaluate both the safety and the efficacy of the new Miamo Renewal Peel Serum. This study highlighted that the Miamo Renewal Peel Serum formulated with a patent-pending mixture of new generation acids (ELPA25™) exerts many beneficial effects and it can be successfully employed for sensitive skin.
实际上,由于化学焕肤具有多功能性、临床终点预测的可预测性以及与激光相比更有利的风险特征,因此在化妆品和皮肤科领域的应用不断增加。化学焕肤是治疗某些皮肤疾病以及使皮肤恢复活力和年轻化的一种安全方法。化学焕肤的主要挑战是其耐受性,因为敏感性皮肤是最常见的皮肤疾病之一。
本研究旨在评估含有新一代果酸(ELPA25™)的新型 Miamo Renewal Peel Serum 对敏感皮肤的有效性,与仅用杏仁酸血清和安慰剂相比。
根据活性与安慰剂的半面部实验方案,“体内”研究涉及 30 名 25 至 64 岁之间的健康白种女性志愿者,她们均有敏感性皮肤,分为两组。ELPA25™血清每周应用三次,持续 8 周。另一组,按照相同的方案,应用含有杏仁酸的活性血清作为对照,与安慰剂进行比较。特别评估了皮肤保湿、皮肤粘弹性、皮肤表面光滑度、皱纹减少和角质层更新。
从敏感皮肤的角度来看,焕肤精华液耐受性良好。与杏仁酸血清和安慰剂相比,治疗 2 个月后,皮肤粗糙度和皱纹宽度显著降低,皮肤紧实度和弹性得到改善。
使用自我对照研究方法和非侵入性皮肤生物工程技术,以及适当的统计方法的科学方案,能够评估新型 Miamo Renewal Peel Serum 的安全性和有效性。这项研究表明,含有专利申请中新一代果酸(ELPA25™)混合物的 Miamo Renewal Peel Serum 具有多种有益作用,可成功用于敏感性皮肤。